Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
REAGILA (Gedeon Richter Australia Pty Ltd)
Product name
REAGILA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 working days (255)
Active ingredients
cariprazine hydrochloride
Registration type
NCE/NBE
Indication
REAGILA (hard capsule) is indicated for the treatment of schizophrenia in adult patients.